Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review

Free Radical Research

Volumn 36, Issue 12, 2002, Pages 1307-1313

  Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Methionine; Alzheimer's disease; Amyloid peptide; Lipid peroxidation; Oxidation stress; Protein oxidation

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASPARTIC ACID; BETA ACTIN; CARBONYL DERIVATIVE; CREATINE KINASE; CYTOSKELETON PROTEIN; DIHYDROPYRIMIDINASE; DNA; ENOLASE; FREE RADICAL; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLYCINE; HYDROLASE; ISOLEUCINE; METHIONINE; OXYGEN; PROLINE; PROTEASOME; REACTIVE OXYGEN METABOLITE; SCAVENGER; UBIQUITIN C; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE; PEPTIDE FRAGMENT;

ALLELE; ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN MEMBRANE; CARBOXY TERMINAL SEQUENCE; CHEMICAL INTERACTION; CLINICAL STUDY; DISEASE MODEL; HIPPOCAMPUS; HUMAN; HYPOTHESIS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; LIPID PEROXIDATION; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN MODIFICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYNAPTOSOME; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; LIPID BILAYER; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; FREE RADICAL SCAVENGERS; HUMANS; LIPID BILAYERS; METHIONINE; MOLECULAR SEQUENCE DATA; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES;

EID: 0036905921     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/1071576021000049890     Document Type: Review

References (64)

1. Butterfield, D.A., Drake, J., Pocernich, C. and Castegna, A. (2001) "Evidence of oxidative damage in Alzheimer's disease brain: central role of amyloid β-peptide", Trends Mol. Med. 7, 548-554.
2. Butterfield, D.A. and Lauderback, C.M. (2002) "Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress", Free Radic. Biol. Med. 32, 1050-1060.
3. Selkoe, D.J. (2001) "Clearing the brain's amyloid cobwebs", Neuron 25, 177-180.
4. Butterfield, D.A., Castegna, A., Lauderback, C.M. and Drake, J. (2002) "Review: evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contributes to neuronal death", Neurobiol. Aging, In press.
5. Varadarajan, S., Yatin, S., Aksenova, M. and Butterfield, D.A. (2000) "Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity", J. Struct. Biol. 130, 184-208.
6. Butterfield, D.A. (1997) "β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease", Chem. Res. Toxicol. 10, 495-506.
7. Yatin, S.M., Link, C.D. and Butterfield, D.A. (1999) "In-vitro and in-vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)", Neurobiol. Aging 20, 325-330.
8. Yatin, S.M., Yatin, M., Aulick, T., Ain, K.B. and Butterfield, D.A. (1999) "Alzheimer's amyloid β-peptide generated free radicals increase rat embryonic neuronal polyamine uptake and ODC activity: protective effect of vitamin E", Neurosci. Lett. 263, 17-20.
9. Yatin, S.M., Yatin, M., Varadarajan, S., Ain, K.B. and Butterfield, D.A. (2001) "Role of spermine and amyloid β-peptide (1-42) associated free radical oxidative stress induced neurotoxicity", J. Neurosci. Res. 63, 395-401.
10. Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C.M. and Butterfield, D.A. (2001) "Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)", J. Am. Chem. Soc. 123, 5625-5631.
11. Yatin, S.M., Varadarajan, S., Aksenova, M. and Butterfield, D.A. (2000) "Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced protein oxidation and reactive species formation", J. Alzheimer Dis. 2, 123-131.
12. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S.P., Wu, J.F., Carney, J.M., Lovell, M.A., Markesbery, W.R. and Butterfield, D.A. (1995) "Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation", J. Neurochem. 65, 2146-2156.
13. Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A. and Markesbery, W.R. (1991) "Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease", Proc. Natl Acad. Sci. USA 88, 10540-10543.
14. Butterfield, D.A., Hensley, K., Harris, M., Mattson, M. and Carney, J. (1994) "β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion", Biochem. Biophys. Res. Commun. 200, 710-715.
15. Avdulov, N.A., Chochina, S.V, Igbavboa, U., O'Hare, E.O., Schroeder, F., Cleary, J.P. and Wood, G.W.G. (1997) "Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes", J. Neurochem. 68, 2086-2091.
16. Bruce-Keller, A.J., Begley, J.G., Fu, W., Butterfield, D.A., Bredesen, D.E., Hutchins, J.B., Hensley, K. and Mattson, M.P. (1998) "Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide", J. Neurochem. 70, 31-39.
17. Mark, R.J., Lovell, M.A., Markesbery, W.R., Uchida, K. and Mattson, M.P. (1997) "A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide", J. Neurochem. 68, 255-264.
18. Mark, R.J., Pang, Z., Geddes, J.W., Uchida, K. and Mattson, M.P. (1997) "Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation", J. Neurosci. 17, 1046-1054.
19. Mark, R.J., Fuson, K.S. and May, P.C. (1999) "Characterization of 8-epiprostaglandin F2alpha as a marker of amyloid β-peptide-induced oxidative damage", J. Neurochem. 72, 1146-1153.
20. Daniels, W.M., van Rensburg, S.J., van Zyl, J.M. and Taljaard, J.J. (1998) "Melatonin prevents beta-amyloid-induced lipid peroxidation", J. Pineal Res. 24, 78-82.
21. Gridley, K.E., Green, P.S. and Simpkins, J.W. (1997) "Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation, and glucose utilization in human SK-N-SH neuroblastoma cells", Brain Res. 778, 158-165.
22. Lauderback, C.M., Hackett, J.M., Huang, F.F., Keller, J.N., Szweda, L.I., Markesbery, W.R. and Butterfield, D.A. (2001) "The glial glutatmate transporter Glt-1 is oxidatively modified by 4-hydroxy-2-nonenal in Alzheimer's disease brain: role of Aβ(1-42)", J. Neurochem. 78, 413-416.
23. Koppal, T., Subramaniam, R., Drake, J., Prasad, M.R., Dhillon, H. and Butterfield, D.A. (1998) "Vitamin E protects against amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition", Brain Res. 786, 270-273.
24. Markesbery, W.R. (1997) "Oxidative stress hypothesis in Alzheimer's disease", Free Radic. Biol. Med. 23, 134-147.
25. Oda, T., Wals, P., Osterburg, H.H., Johnson, S.A., Pasinetti, G.M., Morgan, T.E., Rozovsky, I., Stine, W.B., Snyder, S.W. and Holzman, T.F. (1995) "Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress", Exp. Neurol. 136, 22-31.
26. Klein, W.L. (2002) "ADDLs and protofibrils-the missing links?", Neurobiol. Aging 23, 231-235.
27. Aksenov, M.Y., Aksenova, M.V., Butterfield, D.A., Hensley, K., Vigo-Pelfrey, C. and Carney, J.M. (1996) "Glutamine synthetase-induced neurotoxicity accompanied by abrogation of fibril formation and amyloid β-peptide fragmentation", J. Neurochem. 66, 2050-2056.
28. Walsh, D.M., Hartley, D.M., Kusumoto, Y., Fezoui, Y., Condron, M.M., Lomakin, A., Benedek, G.B., Selkoe, D.J. and Teplow, D.B. (1999) "Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates", J. Biol. Chem. 274, 25945-25952.
29. Walsh, D.M., Klyubin, I., Fadeeva, J.V., cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. and Selkoe, D.J. (2002) "Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo", Nature 416, 535-539.
30. Markesbery, W.R. and Lovell, M.A. (1998) "4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease", Neurobiol. Aging 19, 33-36.
31. Lovell, M.A., Xie, C. and Markesbery, W.R. (2001) "Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures", Neurobiol. Aging 22, 187-194.
32. Esterbauer, H., Schaur, R.J. and Zollner, H. (1991) "Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes", Free Radic. Biol. Med. 11, 81-128.
33. Butterfield, D.A. and Stadtman, E.R. (1997) "Protein oxidation processes in aging brain", Adv. Cell Aging Gerontol. 2, 161-191.
34. Masliah, E., Alford, M., Deteresa, R., Mallory, M. and Hensen, L. (1996) "Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease", Ann. Neurol. 40, 759-766.
35. Butterfield, D.A., Hensley, K., Cole, P., Subramanaim, R., Aksenov, M., Aksenova, M., Bummer, P.M., Haley, B.E. and Carney, J.M. (1997) "Oxidatively-induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease", J. Neurochem. 68, 2151-2157.
36. Aksenov, M.Y., Aksenova, M.V., Carney, J.M. and Butterfield, D.A. (1997) "Oxidative modification of glutamine synthetase by amyloid β-peptide", Free Radic. Res. 27, 267-281.
37. Butterfield, D.A. and Pocernich, C.B. (2002) "The glutamatergic system and Alzheimer's disease: therapeutic implications", CNS Drugs, In press.
38. 2+ homeostasis and cell death", J. Neurosci. 15, 6239-6249.
39. Keller, J.N., Mark, R.J., Bruce, A.J., Blanc, E., Rothstein, J.D., Uchida, K., Waeg, G. and Mattson, M.P. (1997) "4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes", Neuroscience 80, 685-696.
40. Subramaniam, R., Roediger, F., Jordan, B., Mattson, M.P., Keller, J.N., Waeg, G. and Butterfield, D.A. (1997) "The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins", J. Neurochem. 69, 1161-1169.
41. Pocernich, C.B., Cardin, A., Racine, C., Lauderback, C.M. and Butterfield, D.A. (2001) "Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease", Neurochem. Int. 39, 141-149.
42. Shao, H., Jao, S.-C., Ma, K. and Zagorski, M.G. (1999) "Solution structures of micelle-bound amyloid β(1-40) and β(1-42) peptides of Alzheimer's disease", J. Mol. Biol. 285, 755-773.
43. Coles, M., Bicknell, W., Watson, A.A., Fairlie, D.P. and Craik, D.J. (1998) "Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?", Biochemistry 37, 11064-11077.
44. Kanski, J., Aksenova, M., Schoneich, C. and Butterfield, D.A. (2002) "Substitution of isoleucine-31 by helical-breaking proline abolishes stress and neurotoxic properties of Alzheimer's amyloid β-peptide (1-42)", Free Radic. Biol. Med. 32, 1205-1211.
45. Halliwell, B. and Gutteridge (1989) Free Radicals in Biology and Medicine (Clarendon, Oxford).
46. Curtain, C.C., Ali, F., Volitakis, I., Cherny, R.A., Norton, R.S., Beyreuther, K., Barrow, C.J., Masters, C.L., Bush, A.I. and Barnham, J.J. (2001) "Alzheimer's disease amyloid binds copper an zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits", J. Biol. Chem. 276, 20466-20473.
47. Kanski, J., Aksenova, M. and Butterfield, D.A. (2002) "The hydrophobic environment of Met35 of Alzheimer's Aβ(1-42) is important for the neurotoxic and oxidative properties of the peptide", Neurotoxicity Res. 4, 219-223.
48. Mahley, R. (1988) "Apolipoprotein E: cholesterol transport protein with expanding role in cell biology", Science 240, 622-630.
49. Beffert, U., Cohn, J.S., Petit-Turcottee, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J. and Poirier, J. (1999) "Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent", Brain Res. 843, 87-94.
50. Keller, J.N., Lauderback, C.M., Butterfield, D.A., Kindy, M.S. and Markesbery, W.R. (2000) "Potential role for apolipoprotein E in maintaining synaptic homeostasis", J. Neurochem. 74, 1579-1586.
51. Lauderback, C.M., Hackett, J.M., Keller, J.N., Varadarajan, S., Szweda, L., Kindy, M., Markesbery, W.R. and Butterfield, D.A. (2001) "Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by Aβ(1-40)", Biochemistry 40, 2548-2554.
52. Lauderback, C.M., Kanski, J., Hackett, J.M., Maeda, N., Kindy, M.S. and Butterfield, D.A. (2002) "Apolipoprotein E modulates Alzheimer's Aβ(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner", Brain Res. 924, 90-97.
53. Aksenov, M.Y., Aksenova, M.V., Butterfield, D.A. and Markesbery, W.R. (2000) "Oxidative modification of creatine kinase BB in Alzheimer's disease brain", J. Neurochem. 74, 2520-2527.
54. Aksenov, M.Y., Aksenova, M.V., Butterfield, D.A., Geddes, J.W., Markesbery, W.R. (2001) "Protein oxidation in the Alzheimer's disease brain: analysis of protein carbonyls by immunochemistry and two-dimensional western blotting", Neuroscience 103, 373-383.
55. Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J.B., Pierce, W.M., Booze, R., Markesbery, W.R. and Butterfield, D.A. (2002) "Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part I. Creatine kinase BB, glutamine synthetase, and ubiquitin C-terminal hydrolase L-1", Free Radic. Biol. Med. 33, 562-571.
56. Castegna, A., Aksenov, M., Thongboonkerd, V., Klein, J.B., Pierce, W.M., Booze, R., Markesbery, W.R. and Butterfield, D.A. (2002) "Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part II. Dihydropyrimidinase-related protein 2, α-enolase, and heat shock cognate 71", J. Neurochem. 82, 1524-1532.
57. Blass, J.P. (2001) "Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?", J. Neurosci. Res. 66, 851-856.
58. Yatin, S.M., Aksenov, M. and Butterfield, D.A. (1991) "The antioxidant vitamin E modulated amyloid β-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease", Neurochem. Res. 24, 427-435.
59. Keller, J.N., Gee, J. and Ding, Q. (2002) "The proteasome in brain aging", Aging Res. Rev. 1, 279-293.
60. Shringarpure, R. and Davies, K.J. (2002) "Protein turnover by the proteosome in aging and disease", Free Radic. Biol. Med. 32, 1084-1089.
61. Lee, M., Hyun, D.H., Marshall, K.A., Ellerby, L.M., Bredesen, D.E., Jenner, P. and Halliwell, B. (2001) "Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome", Free Radic. Biol. Med. 31, 1550-1559.
62. Keller, J., Hanni, K.B. and Markesbery, W.R. (2000) "Impaired proteasome function in Alzheimer's disease", J. Neurochem. 75, 436-439.
63. Kurihaka, L.K., Kikuchi, T., Wada, K. and Tilghman, S.M. (2001) "Loss of Uch L-1 and Uch L-3 leads to neurodegenaration, posterior paralysis, and dysphagia", Human Mol. Genet. 10, 1963-1970.
64. Gu, Y. and Ihara, Y. (2000) "Evidence that collapsin response mediator protein-2 is involved in the dynamics of micro-tubules", J. Biol. Chem. 275, 17917-17920.